Almost 98 million people in India may have type 2 diabetes by 2030, according to a study, which found that the number of adults with the disease worldwide is expected rise by over a fifth.
Insulin is essential for all people with type 1 diabetes and some people with type 2 diabetes to reduce the risk of complications such as blindness, amputation, kidney failure, and stroke .
While Type-2 diabetes is expected to rise by more than a fifth, from 406 million in 2018 to 511 million in 2030 globally, India along with China and the United States will share over half of these high blood sugar cases, say researchers led by one of an Indian-origin, while asserting the need to improve access for the life saving insulin.
But a study showcases that 79 million people with Type 2 will need it by 2030, and around half of them may not get access to it.
"The number of adults with type 2 diabetes is expected to rise over the next 12 years due to aging, urbanization and associated changes in diet and physical activity", said Basu.
Only three major companies produce the majority of the world's insulin and, at least according to a lawsuit filed a year ago, may have conspired to drive up the drug's cost.
The number of people with type 2 diabetes worldwide has been estimated to increase from 405.6 million in 2018 to 510·8 million by 2030, according to study by a Stanford University-led research team released on November 20.
India had 69.2 million people living with diabetes in 2015 says a report of the World Health Organization
The study was published Tuesday in the journal The Lancet Diabetes & Endocrinology.
Editor's note: Eating a healthy diet low in carbohydrate, sugar and processed food can help to lower blood glucose levels, and people with type 2 diabetes have been able to put the condition into remission, coming off all their diabetes medication, by following a healthy eating plan.
"In spite of the UN's promise to treat non-communicable illness and guarantee global access to drugs for diabetes, over most part of the world insulin is rare and superfluously troublesome for patients to have an access".
The diagnosis of both types has become more common over the last 30 years, especially in low-income and middle-income countries.
While governments continue to encourage healthier lifestyles to prevent type 2 diabetes, the authors of the study also hope for initiatives to make life-changing insulin available and affordable.
In 2016 an article in the Journal of the American Medical Association reported that the drug's price nearly tripled between 2002 and 2013.